Showing results (91-100 of 142) with videos related to

Sort By:
Pageof 15
Journal of Immunological Methods|January 1, 1981
Monocyte purification with counterflow centrifugation monitored by continuous flow cytometryP H De Mulder, J M Wessels, D A Rosenbrand, et al.
Journal of Chromatography|June 10, 1983
Determination of sparsomycin in plasma and urine of the dog by means of reversed-phase high-performance liquid chromatography and first pharmacokinetic resultsB Winograd, M J Oosterbaan, E van der Kleijn, et al.
British Journal of Cancer|August 1, 1987
Modulation of placental alkaline phosphatase activity and cytokeratins in human HN-1 cells by butyrate, retinoic acid, catecholamines and histamineJ T Bijman, D J Wagener, H van Rennes, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 15, 1998
Enhanced myelotoxicity due to granulocyte colony-stimulating factor administration until 48 hours before the next chemotherapy course in patients with small-cell lung carcinomaV C Tjan-Heijnen, B Biesma, J Festen, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|January 1, 1991
Results of the first ESMO examination in medical oncology, London 1989P Alberto, B Mermillod, P G Cocconi, et al.
Anticancer Research|November 1, 1996
Glutathione S-transferases in gastric carcinomas and in adjacent normal gastric epithelium: immunohistochemical and biochemical analysesD I Schipper, M J Wagenmans, W H Peters, et al.
Cancer|June 15, 1990
Hypothyroidism and goiter in a patient during treatment with interleukin-2V J Mattijssen, P H De Mulder, P A Van Liessum, et al.
Anti-Cancer Drugs|February 1, 1994
Concentration and sequence dependent synergism of ethyldeshydroxy-sparsomycin in combination with antitumor agentsH P Hofs, D J Wagener, V de Valk-Bakker, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|February 1, 1995
Phase II trial of CPT-11 in patients with advanced pancreatic cancer, an EORTC early clinical trials group studyD J Wagener, H E Verdonk, L Y Dirix, et al.
Bulletin Du Cancer|March 1, 1993
[Combination of 5-FU, high dose methotrexate, epirubicin and cisplatin (FEMTX-P protocol) in non surgical or locally recurrent metastatic gastric cancers]T Conroy, J Wils, B Paillot, et al.
Pageof 15